Clonal heterogeneity in growth kinetics of CD34+CD38- human cord blood cells in vitro is correlated with gene expression pattern and telomere length

Stem Cells

Volumn 23, Issue 7, 2005, Pages 946-957

  Bartolović, Kerol ^a   Balabanov, Stefan ^a   Berner, Birgit ^a   Bühring, Hans Jörg ^a   Komor, Martina ^b   Becker, Sven ^a   Hoelzer, Dieter ^b   Kanz, Lothar ^a   Hofmann, Wolf Karsten ^b   Brümmendorf, Tim H ^a,c  

^a UNIVERSITY HOSPITAL TÜBINGEN   (Germany)

^b UNIVERSITY HOSPITAL FRANKFURT   (Germany)

^c UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

Author keywords

CD34+; Cell cycle heterogeneity; Cord blood; Gene expression; Hematopoietic progentitor cells; Telomerase; Telomere

Indexed keywords

CD34 ANTIGEN; CD38 ANTIGEN; GROWTH FACTOR;

ARTICLE; BONE MARROW CELL; CELL GROWTH; CELL PROLIFERATION; CLONAL VARIATION; COLONY FORMING UNIT; FLUORESCENCE IN SITU HYBRIDIZATION; GENE EXPRESSION PROFILING; HEMATOPOIETIC STEM CELL; HUMAN; HUMAN CELL; MOLECULAR CLONING; NUCLEOTIDE SEQUENCE; SARCOMERE LENGTH; TELOMERE; UMBILICAL CORD BLOOD;

ADP-RIBOSYL CYCLASE; ANTIGENS, CD; ANTIGENS, CD34; ANTIGENS, CD38; CELL PROLIFERATION; CELL SEPARATION; CULTURE MEDIA, SERUM-FREE; FETAL BLOOD; FLOW CYTOMETRY; GENE EXPRESSION REGULATION; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; KINETICS; LIGHT; MEMBRANE GLYCOPROTEINS; METHYLCELLULOSE; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; RETROSPECTIVE STUDIES; SCATTERING, RADIATION; STEM CELL FACTOR; STEM CELLS; TELOMERE; TIME FACTORS;

EID: 23844506822     PISSN: 10665099     EISSN: None     Source Type: Journal    
DOI: 10.1634/stemcells.2004-0311     Document Type: Article

References (42)

1. Till JE, McCulloch EA. A direct measurement of the radiation sensitivity of normal mouse bone marrow cells. Radiat Res 1961;14:213-222.
2. Lansdorp PM, Dragowska W, Mayani H. Ontogeny-related changes in proliferative potential of human hematopoietic cells. J Exp Med 1993;178:787-791.
3. Guenechea G, Gan OI, Dorrell C et al. Distinct classes of human stem cells that differ in proliferative and self-renewal potential. Nat Immunol 2001;2:75-82.
4. Kondo M, Wagers AJ, Manz MG et al. Biology of hematopoietic stem cells and progenitors: implications for clinical application. Annu Rev Immunol 2003;21:759-806.
5. Civin CI, Strauss LC, Brovali C et al. Antigenic analysis of hematopoiesis, III: a hematopoietic progenitor cell surface antigen defined by a monoclonal antibody raised against KG-1a cells. J Immunol 1984;133:157-165.
6. Krause DS, Fackler MJ, Civin CI et al. CD34: structure, biology, and clinical utility. Blood 1996;87:1-13.
7. DiGiusto D, Chen S, Combs J et al. Human fetal bone marrow early progenitors for T. B. and myeloid cells are found exclusively in the population expressing high levels of CD34. Blood 1994;84:421-432.
8. Deaglio S, Canella D, Bai G et al. Evidence of an immunologic mechanism behind the therapeutical effects of arsenic trioxide (As(2)O(3)) on myeloma cells. Leuk Res 2001;25:227-235.
9. Baum CM, Weissman IL, Tsukamoto AS et al. Isolation of a candidate human hematopoietic stem-cell population. Proc Natl Acad Sci U S A 1992;89:2804-2808.
10. +. Blood 1998;91:4145-4151.
11. - hematopoietic stem cells. Blood 1994;83:1515-1526.
12. - progenitors give rise to natural killer cells, B-lineage cells, dendritic cells, and myeloid cells. Blood 1999;93:96-106.
13. Hao QL, Thiemann FT, Petersen D et al. Extended long-term culture reveals a highly quiescent and primitive human hematopoietic progenitor population. Blood 1996;88:3306-3313
14. Petzer AL, Hogge DE, Landsdorp PM et al. Self-renewal of primitive human hematopoietic cells (long-term-culture-initiating cells) in vitro and their expansion in defined medium. Proc Natl Acad Sci U S A 1996;93:1470-1474.
15. Bhatia M, Wang JC, Kapp U et al. Purification of primitive human hematopoietic cells capable of repopulating immune-deficient mice. Proc Natl Acad Sci U S A 1997;94:5320-5325.
16. Larochelle A, Vormoor J, Hanenberg H et al. Identification of primitive human hematopoietic cells capable of repopulating NOD/SCID mouse bone marrow: implications for gene therapy. Nat Med 1996;2:1329-1337.
17. Brümmendort TH, Dragowska W, Zijlmans JMJM et al. Asymmetric cell divisions sustain long-term hematopoiesis from single-sorted human fetal liver cells. J Exp Med 1998;188:1117-1124.
18. Rufer N, Brümmendorf TH, Kolvraa S et al. Telomere fluorescence measurements in granulocytes and T lymphocyte subsets point to a high turnover of hematopoietic stem cells and memory T cells in early childhood. J Exp Med 1999;190:157-167.
19. Rufer N, Dragowska W, Thornbury G et al. Telomere length dynamics in human lymphocyte subpopulations measured by flow cytometry. Nat Biotechnol 1998;16:743-747.
20. Chiu CP, Dragowska W, Kim NW et al. Differential expression of telomerase activity in hematopoietic progenitors from adult human bone marrow. STEM CELLS 1996;14:239-248.
21. Yui J, Chiu CP, Lansdorp PM. Telomerase activity in candidate stem cells from fetal liver and adult bone marrow. Blood 1998;91:3255-3262
22. Vaziri H, Dragowska W, Allsopp RC et al. Evidence for a mitotic clock in human hematopoielic stem cells: loss of telomeric DNA with age. Proc Natl Acad Sci U S A 1994;91:9857-9860.
23. Allsopp RC, Cheshier S, Weissman IL. Telomere shortening accompanies increased cell cycle activity during serial transplantation of hematopoietic stem cells. J Exp Med 2001;193:917-924.
24. Notaro R, Cimmino A, Tabarini D et al. In vivo telomere dynamics of human hematopoietic stem cells. Proc Natl Acad Sci U S A 1997;94:13782-13785.
25. Allsopp RC, Morin GB, DePinho R et al. Telomerase is required to slow telomere shortening and extend replicative lifespan of HSC during serial transplantation. Blood 2003;102:517-520
26. Allsopp RC, Morin GB, Horner JW et al. Effect of TERT over-expression on the long-term transplantation capacity of hematopoietic stem cells. Nat Med 2003;9:369-371
27. Allsopp RC, Weissman IL. Replicative senescence of hematopoietic stem cells during serial transplantation: does telomere shortening play a role? Oncogene 2002;21:3270-3273.
28. Phillips RL, Ernst RE, Brunk B et al. The genetic program of hematopoietic stem cells. Science 2000;288:1635-1640.
29. Ivanova NB, Dimos JT, Schaniel C et al. A stem cell molecular signature. Science 2002;298:601-604.
30. Akashi K, He X, Chen J et al. Transcriptional accessibility for genes of multiple tissues and hematopoietic lineages is hierarchically controlled during early hematopoiesis. Blood 2003;101:383-389.
31. + hematopoietic stem and progenitor cells from peripheral blood and bone marrow. Ann NY Acad Sci 2003;996:89-100.
32. de Haan G, Bystrykh LV, Weersing E et al. A genetic and genomic analysis identifies a cluster of genes associated with hematopoietic cell turnover. Blood 2002;100:2056-2062.
33. Bruno L, Hoffmann R, McBlane F et al. Molecular signatures of self-renewal, differentiation, and lineage choice in multipotential hemopoietic progenitor cells in vitro. Mol Cell Biol 2004;24:741-756.
34. Blysczuk P, Czyz J, Kania G et al. Expression of Pax4 in embryonic stem cells promotes differentiation of nestin-positive progenitor and insulin-producing cells. Proc Natl Acad Sci U S A 2003;100:998-1003.
35. Yang Y, Hwang CK, D'Souza UM et al. Three-amino acid extension loop homeodomain proteins Meis2 and TGIF differentially regulate transcription. J Biol Chem 2000;275:20734-20741.
36. Nakamura T, Jenkins NA, Copeland NG. Identification ot a new family of Pbx-related homeobox genes. Oncogene 1996;13:2235-2242.
37. Calvo KR, Knoepfler PS, Sykes DB et al. Meisla suppresses differentiation by G-CSF and promotes proliferation by SCF: potential mechanisms of cooperativity with Hoxa9 in myeloid leukemia. Proc Natl Acad Sci U S A 2001;98:13120-13125.
38. + cells. Eur J Haematol 2003;70:143-150.
39. Arai F, Hirao A, Ohinura M et al. Tie2/angiopoietin-1 signaling regulates hematopoietic stem cell quiescence in the bone marrow niche. Cell 2004;118:149-161.
40. Yuasa H, Takakura N, Shimomura T et al. Analysis of human TIE2 function on hematopoietic stem cells in umbilical cord blood. Biochem Biophys Res Commun 2002;298:731-737.
41. Shivdasani RA, Mayer EL, Orkin SH. Absence of blood formation in mice lacking the T-cell leukaemia oncoprotein tal-I/SCL. Nature 1995;373:432-434.
42. Mikkola HK, Klintman J, Yang H et al. Haematopoietic stem cells retain long-term repopulating activity and multipotency in the absence of stem-cell leukaemia SCL/tal-1 gene. Nature 2003;421:547-551.